MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  


Proventil HFA Inhalation Aerosol

Company: 3M Pharmaceuticals
Approval Status: Approved June 1999
Treatment for: Pulmonary/Respiratory Diseases
Areas: Respiratory

| General Information |


General Information

The approval of Proventil HFA (albuterol sulfate) Inhalation Aerosol covers a supplemental new drug application that provides for the following: lowering the age from 12 years to 4 years and older for the treatment or prevention of

  • bronchospasm with reversible obstructive airway disease
  • exercise-induced bronchospasm



< back to top

Proventil HFA Inhalation Aerosol Drug Information

The Proventil Hfa Inhalation Aerosol drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.





MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.